Attached files
| file | filename |
|---|---|
| 10-Q - 10-Q - AMAG PHARMACEUTICALS, INC. | a14-19668_110q.htm |
| EX-31.2 - EX-31.2 - AMAG PHARMACEUTICALS, INC. | a14-19668_1ex31d2.htm |
| EX-10.2 - EX-10.2 - AMAG PHARMACEUTICALS, INC. | a14-19668_1ex10d2.htm |
| EX-31.1 - EX-31.1 - AMAG PHARMACEUTICALS, INC. | a14-19668_1ex31d1.htm |
| EXCEL - IDEA: XBRL DOCUMENT - AMAG PHARMACEUTICALS, INC. | Financial_Report.xls |
| EX-32.1 - EX-32.1 - AMAG PHARMACEUTICALS, INC. | a14-19668_1ex32d1.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of AMAG Pharmaceuticals, Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2014 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Scott A. Holmes, Chief Accounting Officer, Treasurer and Senior Vice President of Finance and Investor Relations of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
|
/s/ Scott A. Holmes |
|
|
Scott A. Holmes |
|
|
Chief Accounting Officer, Treasurer and Senior |
|
|
(Principal Financial Officer) |
|
|
|
|
November 7, 2014 |
|